IQVIA Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
10.7%projected annual EPS growth
Analyst Coverage
18analysts covering
FY Revenue (est.)
$17.4Bnext fiscal year
FY EPS (est.)
$12.96next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 27 Oct 2026 |
| Q4 2026 Earnings Release | 4 Feb 2027 |
Monitoring Framework
Key Performance Indicators
R&D Solutions Contracted Backlog Quarterly34.2BTarget: Continued expansion driven by book-to-bill ratios above 1.10x
R&D Solutions Book-to-Bill Ratio Quarterly122.0%Target: Above 1.15x
Adjusted EBITDA Margin Quarterly2,320.0%Target: 23.2% for full-year 2026
Net Leverage Ratio Quarterly3.6xTarget: Below 3.5x
Watch Items
- Interest Expense and Refinancing RatesTrigger: Net interest costs exceeding $80 million year-over-year increaseAction: Re-evaluate adjusted EPS growth models and debt paydown prioritization.
- AI Agent Deployment and CommercializationTrigger: Fewer than 500 AI agents deployed by 2027Action: Assess competitive positioning against specialized software vendors like Veeva Systems.
Research as of 2 Sep 2026